CU-T12-9
CU-T12-9 is a specific TLR1/2 agonist with EC50 of 52.9 nM in HEK-Blue hTLR2 SEAP assay. CU-T12-9 activates both the innate and the adaptive immune systems. CU-T12-9 selectively activates the TLR1/2 heterodimer, not TLR2/6. CU-T12-9 signals through NF-κB and invokes an elevation of the downstream effectors TNF-α, IL-10, and iNOS[1].
Product Specifications
CAS Number
1821387-73-8
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/cu-t12-9.html
Purity
99.96
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CNC1=CC=C(C=C1N2C=C(N=C2)C3=CC=C(C=C3)C(F)(F)F)[N+]([O-])=O
Molecular Formula
C17H13F3N4O2
Molecular Weight
362.31
Precautions
H315, H319, H335
References & Citations
[1]Cheng K, et al. Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists. Sci Adv. 2015;1 (3) . pii: e1400139.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
TLR1; TLR2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Acot5 Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
MAD1L1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
